Episode Details

Citi Trends, Inc. (CTRN) Q2 FY2026 — Q2 FY2026 (thirteen weeks ended August 1, 2026): net sales $211.632m vs $190.750m; comps +10.5%; gross margin 40.6% vs 40.0%; operating loss $1.707m vs income of $3.517m; net loss $0.931m vs income of $3.818m; EPS -$0.11 vs $0.48 basic. Released before the open on Tuesday Aug 25 (8-K accepted 06:52 ET). The shares gapped -12.07% to $65.38, made that the day's low, and closed $69.71, -6.24%, on 6.8x the twelve-month median volume. Citi Trends posted its eighth consecutive quarter of comparable store sales growth: comps +10.5%, sales up 10.9% to $211.6m, gross margin 60bp wider, adjusted SG&A leveraged 260bp. The shares opened 12.07% lower. Two reasons. The sales line was already public - pre-announced on August 10, fifteen days early - and store capital spending has gone $10.1m to $22.7m to a guided $35m-$40m, which is 93.8% of the $38m-$42m of adjusted EBITDA those stores are meant to earn. THE CALL: HOLD (3/5, A REAL EIGHT-QUARTER TURNAROUND WHOSE PROFIT IS ALREADY SPOKEN FOR) — base-case value ~$58.67 vs ~$69.71 today. KEY METRICS: - THE SPINE: capital expenditure went $10.108m in FY2024 to $22.7m in FY2025 to a guided $35m-$40m in FY2026 - 3.71x in two years. Against a guided $38m-$42m of adjusted EBITDA that is 93.8% at the midpoints; FY2025 was 132.1%. Cumulatively the stores have cost $60.2m and produced $57.2m - the store bill runs $3.0m AHEAD of the profit it exists to create. - SO FREE CASH FLOW IS NEGATIVE ON THE COMPANY'S OWN TWO GUIDED RANGES: $40.0m of adjusted EBITDA, less the $5.75m of equity compensation that measure adds back, less $37.5m of capital expenditure = -$3.25m, before working capital and before any cash tax. - AND MANAGEMENT REALLOCATED INSIDE IT: new stores CUT from 25 to 20, remodels RAISED from 50 to 60-65, the capital line left unchanged. At that pace 594 stores cycle every 9.5 years - a running cost, not a project. 26 remodels were done in the quarter, 51 in the half. - THE SALES WERE PUBLISHED 15 DAYS EARLY: on August 10 the company pre-announced Q2 sales of $211.6m and comps of +10.5% at an investor conference. It filed $211.632m on the 25th. The stock traded to $77.91 that day - its twelve-month high - and set its highest close, $76.18, the next session. - THE PRIOR YEAR'S PROFIT WAS A BUILDING: Q2 FY2025 net income of $3.818m included an $11.0m gain on the sale of the Savannah office building - 287% of the whole of it. Ex-gain the comparative operating line was -$7.443m, so the merchandise business improved $5.7m in a quarter in which the printed line fell $5.2m. - THE BUYBACK STOPPED AND A SHELF ARRIVED: $6.315m (250,555 shares) repurchased in the Feb-May 2025 quarter and nothing in the five since, with $40.0m still authorised. The weighted share count ROSE 1.87%. At 08:39 ET on print day - 51 minutes before the open - a $100,000,000 Form S-3, 17.2% of the market value, the first since 2007. - THE STREET: only TWO sell-side targets could be sourced AND dated in all of 2026 - D.A. Davidson (Michael Baker) Buy $81 on Aug 26, and Craig-Hallum Buy $67 dated Mar 17, which pre-dates both quarters of this fiscal year. We value CTRN at $58.67 against $69.71: HOLD, 3/5. Bull $86.45, bear $32.30. What to watch: UP: eight straight quarters of comps, +19.7% two-year; a 46.0% incremental gross margin and 31.6% flow-through to adjusted EBITDA; guidance raised a third time; no debt and $55.9m of cash. DOWN: guided free cash flow of -$3.25m; two years of capex ($60.2m) exceeding two years of adjusted EBITDA ($57.2m); a $100m shelf filed 51 minutes before the open, the first since 2007; short interest 11.7% of float. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.